Veterinary Reference Laboratory Market Worth $7 8 billion prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The publisher brings years of research experience to the 8th edition of this report. The 377-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Veterinary Reference Laboratories Market to Reach $3.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Veterinary Reference Laboratories estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 8.4% over the analysis period 2020-2027.
Share:
ResearchAndMarkets.com s offering.
The publisher brings years of research experience to the 8th edition of this report. The 377-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Veterinary Reference Laboratories Market to Reach $3.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Veterinary Reference Laboratories estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 8.4% over the analysis period 2020-2027.
Clinical Chemistry, one of the segments analyzed in the report, is projected to record a 9% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hematology segment is readjusted to a revised 7.1% CAGR for the ne